ACE inhibitors in pregnancy — GPhC CRA MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: A — Refer promptly for a pregnancy-suitable antihypertensive review
ACE inhibitors should be avoided in pregnancy because of fetal risk, particularly in later pregnancy, and treatment should be reviewed promptly. Suitable alternatives may include labetalol, nifedipine or methyldopa depending on the patient. The pharmacist should not choose and start a replacement independently from a community prescription query.
Reference: BNF; NICE CKS